BioMarin Pharmaceutical Inc. (LON:0HNC)

BioMarin Pharmaceutical Statistics

Total Valuation

LON:0HNC has a market cap or net worth of GBP 7.84 billion. The enterprise value is 7.17 billion.

Market Cap	7.84B
Enterprise Value	7.17B

Important Dates

The last earnings date was Friday, October 24, 2025.

Earnings Date	Oct 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	192.11M
Shares Outstanding	n/a
Shares Change (YoY)	+2.10%
Shares Change (QoQ)	-2.57%
Owned by Insiders (%)	0.78%
Owned by Institutions (%)	91.52%
Float	178.16M

Valuation Ratios

The trailing PE ratio is 20.24 and the forward PE ratio is 10.99.

PE Ratio	20.24
Forward PE	10.99
PS Ratio	3.40
PB Ratio	1.74
P/TBV Ratio	1.87
P/FCF Ratio	12.66
P/OCF Ratio	11.52
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.65, with an EV/FCF ratio of 11.58.

EV / Earnings	18.52
EV / Sales	3.04
EV / EBITDA	11.65
EV / EBIT	13.24
EV / FCF	11.58

Financial Position

The company has a current ratio of 4.83, with a Debt / Equity ratio of 0.10.

Current Ratio	4.83
Quick Ratio	2.84
Debt / Equity	0.10
Debt / EBITDA	0.75
Debt / FCF	0.73
Interest Coverage	66.49

Financial Efficiency

Return on equity (ROE) is 9.07% and return on invested capital (ROIC) is 7.01%.

Return on Equity (ROE)	9.07%
Return on Assets (ROA)	6.15%
Return on Invested Capital (ROIC)	7.01%
Return on Capital Employed (ROCE)	10.44%
Revenue Per Employee	757,155
Profits Per Employee	127,355
Employee Count	3,040
Asset Turnover	0.43
Inventory Turnover	0.45

Taxes

In the past 12 months, LON:0HNC has paid 118.18 million in taxes.

Income Tax	118.18M
Effective Tax Rate	23.39%

Stock Price Statistics

The stock price has decreased by -21.52% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.52%
50-Day Moving Average	54.77
200-Day Moving Average	60.00
Relative Strength Index (RSI)	44.23
Average Volume (20 Days)	2,607

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.54

Income Statement

In the last 12 months, LON:0HNC had revenue of GBP 2.30 billion and earned 387.16 million in profits. Earnings per share was 1.99.

Revenue	2.30B
Gross Profit	1.87B
Operating Income	529.18M
Pretax Income	505.34M
Net Income	387.16M
EBITDA	590.72M
EBIT	529.18M
Earnings Per Share (EPS)	1.99

Balance Sheet

The company has 1.10 billion in cash and 449.52 million in debt, giving a net cash position of 649.90 million.

Cash & Cash Equivalents	1.10B
Total Debt	449.52M
Net Cash	649.90M
Net Cash Per Share	n/a
Equity (Book Value)	4.51B
Book Value Per Share	23.46
Working Capital	2.27B

Cash Flow

In the last 12 months, operating cash flow was 679.94 million and capital expenditures -60.89 million, giving a free cash flow of 619.06 million.

Operating Cash Flow	679.94M
Capital Expenditures	-60.89M
Free Cash Flow	619.06M
FCF Per Share	n/a

Margins

Gross margin is 81.32%, with operating and profit margins of 22.99% and 16.82%.

Gross Margin	81.32%
Operating Margin	22.99%
Pretax Margin	21.95%
Profit Margin	16.82%
EBITDA Margin	25.66%
EBIT Margin	22.99%
FCF Margin	26.89%

Dividends & Yields

LON:0HNC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.10%
Shareholder Yield	-2.10%
Earnings Yield	4.94%
FCF Yield	7.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HNC has an Altman Z-Score of 5.84 and a Piotroski F-Score of 7.

Altman Z-Score	5.84
Piotroski F-Score	7